Pharmaceutical-Grade Sodium Chloride Market - Global Forecast To 2030
商品番号 : SMB-91272
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年11月 |
| ページ数 | 253 |
| 図表数 | 282 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
医薬品グレード塩化ナトリウム市場 – グレード（API-NaCl、HD-NaCl）、用途（注射剤／静脈内溶液、透析、経口補水塩、血液濾過溶液、機械的洗浄溶液）、および地域別 – 2030年までの世界予測
医薬品グレード塩化ナトリウム市場規模は、2025年には5億9,000万米ドルと推定され、2030年には7億7,000万米ドルに達すると予測されています。2025年から2030年にかけての年平均成長率（CAGR）は5.6%です。慢性腎臓病（CKD）、糖尿病、脱水症などの慢性疾患の罹患率が継続的に上昇する中、点滴液、注射剤、透析液の需要増加により、医薬品グレード塩化ナトリウム市場は拡大するでしょう。新興国を含む医薬品および生物製剤の生産増加も、薬局方に適合する高純度塩化ナトリウムの需要増加に寄与しています。インフラ設備への投資、救命救急医療への政府支出、サプライチェーン設備の強化も、市場の成長を牽引しています。
調査対象範囲：
本調査レポートは、医薬品グレード塩化ナトリウム市場を、グレード（API-NaClおよびHD-NaCl）、用途（注射剤／静脈内注射液、透析、経口補水塩、血液濾過液、機械的洗浄液、その他の用途）、および地域（アジア太平洋、北米、欧州、南米、中東・アフリカ）に基づいて分類しています。本レポートは、市場の成長に影響を与える推進要因、制約要因、課題、機会に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、各社の事業概要、提供製品、そして市場に関連する提携、事業拡大、買収などの主要戦略に関する洞察を提供しています。また、本レポートでは、医薬品グレード塩化ナトリウム市場エコシステムにおける新興企業の競合分析も行っています。
レポートを購入する理由
本レポートは、市場リーダーおよび新規参入企業に対し、医薬品グレード塩化ナトリウム市場全体とそのサブセグメントの収益数値に関する近似値に関する情報を提供します。本レポートは、ステークホルダーが競争環境を理解し、より効果的な事業ポジショニングのためのより深い洞察を獲得し、適切な市場開拓戦略を策定するのに役立ちます。また、本レポートは、ステークホルダーが市場を理解し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供するのに役立ちます。
本レポートでは、以下の点について洞察を提供しています。
- 主要な推進要因（透析治療の増加）、制約要因（複雑な規制承認）、機会（発展途上地域における医療投資の増加）、課題（監査と文書化の負担）の分析
- 製品開発／イノベーション：医薬品グレード塩化ナトリウム市場における今後の技術、研究開発活動、製品・サービスの投入に関する詳細な洞察
- 市場開発：収益性の高い市場に関する包括的な情報（本レポートでは、様々な地域における医薬品グレード塩化ナトリウム市場を分析しています）
- 市場多様化：医薬品グレード塩化ナトリウム市場における新製品・サービス、未開拓地域、最近の動向、投資に関する包括的な情報
- 競合評価：K+S Aktiengesellschaft（ドイツ）、Südwestdeutsche Salzwerke AG（ドイツ）、Dominion Salt（ニュージーランド）、Morton Salt, Inc.（米国）、Salinen Austria AG（オーストリア）などの主要企業の市場シェア、成長戦略、サービス提供に関する詳細な評価
Report Description
The pharmaceutical-grade sodium chloride market size is estimated to be USD 0.59 billion in 2025 and is projected to reach USD 0.77 billion by 2030, at a CAGR of 5.6% from 2025 to 2030. The pharmaceutical-grade sodium chloride market will expand owing to the rise in the demand for intravenous fluids, the injectable formulations, and dialysis solutions as the prevalence of chronic diseases like chronic kidney disease (CKD), diabetes, and dehydration disorders continues to rise. The increased production of pharmaceuticals and biologics, including in the emerging economies, is also contributing to the demand for high-purity sodium chloride that is pharmacopeially acceptable. Investment in infrastructure facilities, government expenditure on critical care, and enhancements to supply chain facilities are also driving the market’s growth.
“HD-NaCl segment is projected to exhibit the highest CAGR from 2025 to 2030”
The HD-NaCl is expected to record the highest CAGR in the pharmaceutical-grade sodium chloride market during the forecast period, owing to the rising demand for critical care therapies and hydration therapies provided in hospitals. Consumption of HD sodium chloride is on the rise. It is cheaper and can be produced in large quantities, making it the preferred choice over API sodium chloride for large-scale pharmaceutical and clinical usage.
“Dialysis segment is projected to capture the largest market share in 2030”
The largest application in the pharmaceutical-grade sodium chloride market is dialysis due to the rapidly rising incidences of CKD associated with older people, diabetes, and hypertension. The growth of dialysis facilities and the introduction of home dialysis units worldwide only escalates the market demand. The dialytic modalities of hemodialysis and peritoneal dialysis necessitate constant and high-volume utilization of pharmaceutical-grade sodium chloride to formulate the dialysates.
“Asia Pacific pharmaceutical-grade sodium chloride market is projected to grow at the highest CAGR during the forecast period”
The Asia Pacific is experiencing high growth in the pharmaceutical-grade sodium chloride market due to the rapid development of the pharmaceutical and biologics production industry, as well as increased investment in hospital and dialysis infrastructure. Favorable government policies and low cost of production deter competitive imported pharmaceutical-grade sodium chloride production. The increased use of modern healthcare in India, China, and Southeast Asia is reinforcing market acceleration.
- By Company Type: Tier 1 – 25%, Tier 2 – 42%, and Tier 3 – 33%
- By Designation: C-level Executives – 20%, Directors – 30%, and Others – 50%
- By Region: North America – 20%, Europe – 10%, Asia Pacific – 40%, South America – 10%, and Middle East & Africa – 20%
Notes: Other designations include sales, marketing, and product managers.
Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: <USD 500 million
Companies Covered: K+S Aktiengesellschaft (Germany), Südwestdeutsche Salzwerke AG (Germany), Dominion Salt (New Zealand), Morton Salt, Inc. (US), and Salinen Austria AG (Austria), among other companies, are covered in the report.
The study includes an in-depth competitive analysis of these key players in the pharmaceutical-grade sodium chloride market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the pharmaceutical-grade sodium chloride market based on grade (API-NaCl and HD-NaCl), application (injectables/intravenous solutions, dialysis, oral rehydration salts, hemofiltration solutions, mechanical cleansing solutions, and other applications), and region (Asia Pacific, North America, Europe, South America, and the Middle East & Africa). The report’s scope covers detailed information regarding the drivers, restraints, challenges, and opportunities influencing the growth of the market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products offered, and key strategies, such as partnerships, expansions, and acquisitions, associated with the market. This report also covers a competitive analysis of upcoming startups in the pharmaceutical-grade sodium chloride market ecosystem.
Reasons to Buy the Report
The report will provide market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall pharmaceutical-grade sodium chloride market and its subsegments. This report will help stakeholders understand the competitive landscape, gain deeper insights into positioning their businesses more effectively, and develop suitable go-to-market strategies. The report will help stakeholders understand the market and provide them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following points:
Analysis of key drivers (Rising dialysis treatments), restraints (Complex regulatory approvals), opportunities (Rising healthcare investment in developing regions), and challenges (Audits and documentation burdens)
- Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the pharmaceutical-grade sodium chloride market
- Market Development: Comprehensive information about profitable markets–the report analyzes the pharmaceutical-grade sodium chloride market across varied regions
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the pharmaceutical-grade sodium chloride market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as K+S Aktiengesellschaft (Germany), Südwestdeutsche Salzwerke AG (Germany), Dominion Salt (New Zealand), Morton Salt, Inc. (US), Salinen Austria AG (Austria)
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 26
1.3.2 INCLUSIONS AND EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 27
1.3.4 CURRENCY CONSIDERED 27
1.3.5 UNIT CONSIDERED 27
1.4 STAKEHOLDERS 28
1.5 SUMMARY OF STRATEGIC CHANGES 28
2 EXECUTIVE SUMMARY 29
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 29
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 30
2.3 DISRUPTIVE TRENDS SHAPING PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 31
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 32
2.5 SNAPSHOT: ASIA PACIFIC MARKET SIZE AND FORECAST 33
3 PREMIUM INSIGHTS 34
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 34
3.2 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE AND REGION 35
3.3 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM 35
3.4 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION 36
3.5 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY 36
4 MARKET OVERVIEW 37
4.1 INTRODUCTION 37
4.2 MARKET DYNAMICS 38
4.2.1 DRIVERS 38
4.2.1.1 Rising dialysis treatments 38
4.2.1.2 Strong demand for pharmaceutical-grade sodium chloride in North America and Europe 40
4.2.1.3 Emerging markets driving healthcare expansion and increasing demand 41
4.2.2 RESTRAINTS 41
4.2.2.1 Complex regulatory approvals 41
4.2.2.2 Dependence on stable supply of raw salt 42
4.2.3 OPPORTUNITIES 42
4.2.3.1 Rising healthcare investment in developing regions 42
4.2.3.2 Partnerships with hospitals and pharmaceutical companies 43
4.2.4 CHALLENGES 43
4.2.4.1 Strict audits and documentation burdens 43
4.2.4.2 Competition from local low-cost producers 44
4.3 UNMET NEEDS AND WHITE SPACES 44
4.3.1 UNMET NEEDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 44
4.3.1.1 Need for higher purity and specialized grades 44
4.3.1.2 Digitalization and supply chain transparency 45
4.3.1.3 Enhanced technical support and quality services 45
4.3.1.4 Flexible and long-term supply models 45
4.3.1.5 Skilled quality teams and regulatory assurance 45
4.3.2 WHITE SPACE OPPORTUNITIES 45
4.3.2.1 Expansion into emerging and underserved markets 45
4.3.2.2 Development of specialty and high-performance grades 46
4.3.2.3 Digital quality systems and traceability platforms 46
4.3.2.4 Enhanced technical services and regulatory support 46
4.3.2.5 Integrated supply and capacity-reliability solutions 46
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 47
4.4.1 INTERCONNECTED MARKETS 47
4.4.2 CROSS-SECTOR OPPORTUNITIES 47
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 48
4.5.1 KEY MOVES AND STRATEGIC FOCUS 48
5 INDUSTRY TRENDS 49
5.1 PORTER’S FIVE FORCES’ ANALYSIS 49
5.1.1 THREAT OF NEW ENTRANTS 50
5.1.2 THREAT OF SUBSTITUTES 50
5.1.3 BARGAINING POWER OF SUPPLIERS 50
5.1.4 BARGAINING POWER OF BUYERS 51
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 51
5.2 MACROECONOMIC ANALYSIS 52
5.2.1 INTRODUCTION 52
5.2.2 GDP TRENDS AND FORECASTS 52
5.2.3 URBANIZATION AND DEMOGRAPHIC SHIFTS 53
5.2.4 TRADE AND GLOBAL SUPPLY CHAIN DYNAMICS 54
5.3 VALUE CHAIN ANALYSIS 55
5.3.1 RAW MATERIAL PROCUREMENT AND ACQUISITION 56
5.3.2 PROCESSING, REFINING, AND QUALITY ASSURANCE 56
5.3.3 DISTRIBUTION, LOGISTICS, AND SUPPLY CHAIN MANAGEMENT 57
5.3.4 CONVERSION TO END-USE PHARMACEUTICAL PRODUCTS 57
5.4 ECOSYSTEM ANALYSIS 57
5.5 PRICING ANALYSIS 58
5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY GRADE 59
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 59
5.6 TRADE ANALYSIS 60
5.6.1 IMPORT SCENARIO 61
5.6.2 EXPORT SCENARIO 62
5.7 KEY CONFERENCES AND EVENTS, 2025–2026 64
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 64
5.9 CASE STUDY ANALYSIS 65
5.9.1 EFFICIENT PRODUCTION OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE FROM ROCK SALT AT ENASEL, ALGERIA 65
5.9.2 TRANSFORMING LOW-QUALITY SOLAR SALT INTO PHARMACEUTICAL-GRADE SODIUM CHLORIDE IN BANGLADESH 66
5.10 IMPACT OF 2025 US TARIFF ON PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 66
5.10.1 INTRODUCTION 66
5.10.2 KEY TARIFF RATES 67
5.10.3 PRICE IMPACT ANALYSIS 67
5.10.4 KEY IMPACT ON VARIOUS REGIONS 68
5.10.5 IMPACT ON APPLICATIONS 68
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTIONS 69
6.1 KEY TECHNOLOGIES 69
6.1.1 VACUUM SALT PRODUCTION 69
6.1.2 MECHANICAL VAPOR RECOMPRESSION (MVR) & MULTIPLE-EFFECT EVAPORATION (MEE) 69
6.1.3 RECRYSTALLIZATION 69
6.1.4 COLD BRINE LEACHING & CHEMICAL PRECIPITATION 69
6.2 COMPLEMENTARY TECHNOLOGIES 69
6.2.1 PARTICLE SIZE CONTROL, SIEVING, AND GRANULATION 70
6.2.2 DRYING TECHNOLOGY (HOT AIR & FLUID BED DRYING) 70
6.2.3 PAT & PROCESS AUTOMATION (SCADA, DCS, INLINE QUALITY MONITORING) 70
6.3 ADJACENT TECHNOLOGIES 70
6.3.1 STERILE INTRAVENOUS FLUID, DIALYSIS, AND ORS PRODUCTION SYSTEMS 70
6.3.2 CLEANROOM, HVAC, AND GMP PACKAGING TECHNOLOGIES 70
6.4 TECHNOLOGY/PRODUCT ROADMAP 70
6.4.1 SHORT-TERM (2025–2027) | DIGITAL TRANSITION AND PRODUCTION OPTIMIZATION PHASE 70
6.4.2 MID-TERM (2027–2030): SUSTAINABLE PRODUCTION & SUPPLY CHAIN INTEGRATION 71
6.4.3 LONG-TERM (2030–2035+): BIOPROCESS INTEGRATION & ON-SITE PHARMACEUTICAL BRINE SYSTEMS 72
6.5 PATENT ANALYSIS 72
6.5.1 INTRODUCTION 72
6.5.2 APPROACH 73
6.5.3 TOP APPLICANTS 73
6.6 FUTURE APPLICATIONS 75
6.6.1 ADVANCED APPLICATIONS IN INJECTABLES, DIALYSIS, AND BIOPROCESSING SYSTEMS 75
6.7 IMPACT OF AI/GEN AI ON PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 76
6.7.1 TOP USE CASES AND MARKET POTENTIAL 76
6.7.2 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 77
6.7.3 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 77
6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 78
6.8.1 K+S AKTIENGESELLSCHAFT ENABLES CRITICAL PHARMACEUTICAL SUPPLY SUPPORT DURING GLOBAL COVID-19 VACCINATION ROLLOUT 78
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 79
7.1 REGIONAL REGULATIONS AND COMPLIANCE 79
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
7.1.2 INDUSTRY STANDARDS 82
7.2 SUSTAINABILITY INITIATIVES 83
7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE 83
7.2.1.1 Carbon Impact Reduction 84
7.2.1.2 Eco-Applications 84
7.3 CERTIFICATIONS, LABELING, ECO-STANDARDS 85
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 87
8.1 DECISION-MAKING PROCESS 87
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 89
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
8.2.2 BUYING CRITERIA 90
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 91
8.4 UNMET NEEDS FROM VARIOUS APPLICATIONS 93
8.5 MARKET PROFITABILITY 93
8.5.1 REVENUE POTENTIAL 93
8.5.2 COST DYNAMICS 94
8.5.3 MARGIN OPPORTUNITIES, BY APPLICATION 94
9 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE 95
9.1 INTRODUCTION 96
9.2 HD-NACL 97
9.2.1 UNMATCHED STABILITY, HEIGHT, AND LIFTING POWER TO DRIVE DEMAND 97
9.3 API-NACL 97
9.3.1 HIGH REGULATORY COMPLIANCE, PURITY ASSURANCE, AND FUNCTIONAL PERFORMANCE TO AUGMENT DEMAND 97
10 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM 99
10.1 INTRODUCTION 100
10.2 LIQUID 101
10.2.1 GROWING DEMAND FOR ORAL ELECTROLYTE THERAPIES TO DRIVE DEMAND 101
10.3 SOLID 101
10.3.1 RISING GLOBAL HOSPITALIZATION RATES TO AUGMENT DEMAND 101
11 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION 102
11.1 INTRODUCTION 103
11.2 DIALYSIS 104
11.2.1 GROWING DIALYSIS PATIENT POPULATION TO FUEL MARKET GROWTH 104
11.3 INJECTABLES 105
11.3.1 GROWING USE OF IV THERAPIES AND SURGICAL PROCEDURES TO DRIVE DEMAND 105
11.4 ORAL REHYDRATION SALTS 105
11.4.1 GROWING GLOBAL NEED FOR EFFECTIVE DEHYDRATION MANAGEMENT TO DRIVE DEMAND 105
11.5 HEMOFILTRATION SOLUTIONS 106
11.5.1 ADVANCED RENAL REPLACEMENT REQUIREMENTS TO ACCELERATE DEMAND 106
11.6 MECHANICAL CLEANING SOLUTIONS 107
11.6.1 INCREASING SURGICAL ACTIVITIES AND HOSPITAL HYGIENE STANDARDS TO DRIVE DEMAND 107
11.7 OTHER APPLICATIONS 107
12 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY REGION 109
12.1 INTRODUCTION 110
12.2 ASIA PACIFIC 111
12.2.1 CHINA 115
12.2.1.1 Pharmaceutical industry and shift toward advanced drug development to drive market 115
12.2.2 JAPAN 116
12.2.2.1 Accelerating aging population and rising healthcare demand to drive market 116
12.2.3 INDIA 118
12.2.3.1 Growing generic injectable drug industry to drive market 118
12.2.4 SOUTH KOREA 120
12.2.4.1 Rapidly aging population and rising healthcare demand to propel market 120
12.2.5 REST OF ASIA PACIFIC 122
12.3 EUROPE 124
12.3.1 GERMANY 128
12.3.1.1 Rising renal replacement therapy demand to boost consumption 128
12.3.2 FRANCE 130
12.3.2.1 Growing adoption of home hemodialysis 130
12.3.3 UK 132
12.3.3.1 CKD prevalence and aging population to accelerate market 132
12.3.4 ITALY 134
12.3.4.1 Expanding healthcare infrastructure to drive demand 134
12.3.5 SPAIN 136
12.3.5.1 Strong organ donation infrastructure and rising dialysis volume to accelerate market growth 136
12.3.6 NETHERLANDS 138
12.3.6.1 Increasing CKD incidence and elderly population expansion to support market growth 138
12.3.7 IRELAND 140
12.3.7.1 Increasing incidence of kidney failure and expanding renal care needs to boost market 140
12.3.8 TURKEY 142
12.3.8.1 High incidence of end-stage kidney disease to boost market 142
12.3.9 RUSSIA 143
12.3.9.1 Expanding dialysis centers and rising CKD burden to propel market 143
12.3.10 REST OF EUROPE 145
12.4 NORTH AMERICA 147
12.4.1 US 150
12.4.1.1 Aging population increasing hospital and infusion needs to boost market 150
12.4.2 CANADA 152
12.4.2.1 Rising CKD and expanding dialysis needs to boost market 152
12.4.3 MEXICO 154
12.4.3.1 Rapidly aging population to propel the market 154
12.5 SOUTH AMERICA 155
12.5.1 BRAZIL 158
12.5.1.1 Rising CKD burden and rapid population aging fueling the demand 158
12.5.2 ARGENTINA 160
12.5.2.1 Healthcare modernization and rising chronic disease burden to augment market 160
12.5.3 REST OF SOUTH AMERICA 161
12.6 MIDDLE EAST & AFRICA 163
12.6.1 GCC COUNTRIES 165
12.6.1.1 Saudi Arabia 167
12.6.1.1.1 High CKD and diabetes burden paired with Vision 2030 healthcare expansion to drive market 167
12.6.1.2 UAE 169
12.6.1.2.1 High diabetes and CKD burden to boost market 169
12.6.1.3 Rest of GCC countries 170
12.6.2 SOUTH AFRICA 172
12.6.2.1 Expanding healthcare & dialysis infrastructure to drive market 172
12.6.3 REST OF MIDDLE EAST & AFRICA 174
13 COMPETITIVE LANDSCAPE 176
13.1 OVERVIEW 176
13.2 KEY PLAYER STRATEGIES 176
13.3 REVENUE ANALYSIS 177
13.4 MARKET SHARE ANALYSIS 177
13.5 COMPANY VALUATION AND FINANCIAL METRICS 180
13.5.1 COMPANY VALUATION 180
13.5.2 FINANCIAL METRICS 181
13.6 BRAND/PRODUCT COMPARISON 183
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 184
13.7.1 STARS 184
13.7.2 EMERGING LEADERS 184
13.7.3 PERVASIVE PLAYERS 184
13.7.4 PARTICIPANTS 184
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 186
13.7.5.1 Company footprint 186
13.7.5.2 Region footprint 187
13.7.5.3 Grade footprint 187
13.7.5.4 Product form footprint 188
13.7.5.5 Application footprint 188
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 189
13.8.1 PROGRESSIVE COMPANIES 189
13.8.2 RESPONSIVE COMPANIES 189
13.8.3 DYNAMIC COMPANIES 189
13.8.4 STARTING BLOCKS 189
13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 191
13.8.6 DETAILED LIST OF KEY STARTUPS/SMES 191
13.8.7 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 192
13.9 COMPETITIVE SCENARIO 193
13.9.1 DEALS 193
13.9.2 EXPANSIONS 194
13.9.3 OTHER DEVELOPMENTS 194
14 COMPANY PROFILES 195
14.1 KEY PLAYERS 195
14.1.1 K+S AKTIENGESELLSCHAFT 195
14.1.1.1 Business overview 195
14.1.1.2 Products/Solutions/Services offered 196
14.1.1.3 Recent developments 197
14.1.1.3.1 Others 197
14.1.1.4 MnM view 197
14.1.1.4.1 Key strengths 197
14.1.1.4.2 Strategic choices 198
14.1.1.4.3 Weaknesses and competitive threats 198
14.1.2 SÜDWESTDEUTSCHE SALZWERKE AG 199
14.1.2.1 Business overview 199
14.1.2.2 Products/Solutions/Services offered 200
14.1.2.3 MnM view 201
14.1.2.3.1 Key strengths 201
14.1.2.3.2 Strategic choices 201
14.1.2.3.3 Weaknesses and competitive threats 202
14.1.3 DOMINION SALT 203
14.1.3.1 Business overview 203
14.1.3.2 Products/Solutions/Services offered 203
14.1.3.3 MnM view 204
14.1.3.3.1 Key strengths 204
14.1.3.3.2 Strategic choices 204
14.1.3.3.3 Weaknesses and competitive threats 204
14.1.4 MORTON SALT, INC. 205
14.1.4.1 Business overview 205
14.1.4.2 Products/Solutions/Services offered 205
14.1.4.3 MnM view 206
14.1.4.3.1 Key strengths 206
14.1.4.3.2 Strategic choices 206
14.1.4.3.3 Weaknesses and competitive threats 206
14.1.5 SALINEN AUSTRIA AG 207
14.1.5.1 Business overview 207
14.1.5.2 Products/Solutions/Services offered 207
14.1.5.3 MnM view 208
14.1.5.3.1 Key strengths 208
14.1.5.3.2 Strategic choices 208
14.1.5.3.3 Weaknesses and competitive threats 208
14.1.6 MERCK KGAA 209
14.1.6.1 Business overview 209
14.1.6.2 Products/Solutions/Services offered 211
14.1.6.3 Recent developments 211
14.1.6.3.1 Expansions 211
14.1.6.4 MnM view 212
14.1.7 GROUPE SALINS 213
14.1.7.1 Business overview 213
14.1.7.2 Products/Solutions/Services offered 214
14.1.7.3 Recent developments 214
14.1.7.3.1 Deals 214
14.1.7.4 MnM view 215
14.1.8 HUB SALT 216
14.1.8.1 Business overview 216
14.1.8.2 Products/Solutions/Services offered 216
14.1.8.3 MnM view 217
14.1.9 JIANGSU PROVINCE QINFEN PHARMACEUTICAL CO., LTD. 218
14.1.9.1 Business overview 218
14.1.9.2 Products/Solutions/Services offered 218
14.1.9.3 MnM view 219
14.1.10 US SALT 220
14.1.10.1 Business overview 220
14.1.10.2 Products/Solutions/Services offered 220
14.1.10.3 MnM view 220
14.2 OTHER PLAYERS 221
14.2.1 NANDU CHEMICALS 221
14.2.2 MACCO ORGANIQUES, S.R.O. 222
14.2.3 J J CHEMICALS 223
14.2.4 SALT MINERALS GMBH 224
14.2.5 HITECH MINERALS AND CHEMICALS GROUP 225
14.2.6 TIANJIN HENGHAIXIN INTERNATIONAL TRADING CO., LTD. 226
14.2.7 MARKHOR SALT CO. 227
14.2.8 ABHAY AQUA CHEM 228
14.2.9 HAWKINS 229
14.2.10 RCI LABSCAN LIMITED 230
14.2.11 GLENTHAM LIFE SCIENCES LIMITED 231
14.2.12 FENGCHEN GROUP CO., LTD 232
14.2.13 DHANRAJ SUGAR PVT. LTD. 233
14.2.14 SD FINE-CHEM LTD 234
14.2.15 VM CHEMICALS 235
15 RESEARCH METHODOLOGY 236
15.1 RESEARCH DATA 236
15.1.1 SECONDARY DATA 236
15.1.1.1 Key data from secondary sources 237
15.1.2 PRIMARY DATA 237
15.1.2.1 Key data from primary sources 238
15.1.2.2 Key industry insights 238
15.2 MARKET SIZE ESTIMATION 239
15.3 BASE NUMBER CALCULATION 240
15.3.1 DEMAND-SIDE APPROACH 240
15.3.2 SUPPLY-SIDE APPROACH 241
15.4 MARKET FORECAST APPROACH 241
15.4.1 SUPPLY SIDE 241
15.4.2 DEMAND SIDE 241
15.5 DATA TRIANGULATION 241
15.6 FACTOR ANALYSIS 242
15.7 RESEARCH ASSUMPTIONS 243
15.8 RESEARCH LIMITATIONS AND RISK ASSESSMENT 244
16 APPENDIX 245
16.1 DISCUSSION GUIDE 245
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 249
16.3 CUSTOMIZATION OPTIONS 251
16.4 RELATED REPORTS 251
16.5 AUTHOR DETAILS 252
LIST OF TABLES
TABLE 1 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: IMPACT OF PORTER’S FIVE FORCES ANALYSIS 50
TABLE 2 GLOBAL GDP GROWTH PROJECTION, 2021–2028 (USD TRILLION) 53
TABLE 3 ROLE OF COMPANIES IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE ECOSYSTEM 58
TABLE 4 AVERAGE SELLING PRICE OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE OFFERED BY KEY PLAYERS, BY GRADE, 2024 (USD/KG) 59
TABLE 5 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE, BY REGION, 2023–2025 (USD/KG) 60
TABLE 6 IMPORT DATA FOR HS CODE 250100-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 62
TABLE 7 EXPORT DATA FOR HS CODE 250100-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 63
TABLE 8 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 64
TABLE 9 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: LIST OF
MAJOR PATENTS: 2024 74
TABLE 10 TOP USE CASES AND MARKET POTENTIAL 76
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 14 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 15 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 16 GLOBAL INDUSTRY STANDARDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 82
TABLE 17 CERTIFICATIONS, LABELING, ECO-STANDARDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 85
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION (%) 90
TABLE 19 KEY BUYING CRITERIA, BY APPLICATION 91
TABLE 20 UNMET NEEDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET IN KEY APPLICATIONS 93
TABLE 21 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (USD MILLION) 96
TABLE 22 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (KILOTONS) 97
TABLE 23 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (USD MILLION) 100
TABLE 24 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (KILOTONS) 101
TABLE 25 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 104
TABLE 26 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION,
2023–2030 (KILOTONS) 104
TABLE 27 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY REGION,
2023–2030 (USD MILLION) 110
TABLE 28 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY REGION,
2023–2030 (KILOTON) 111
TABLE 29 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 30 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY COUNTRY, 2023–2030 (KILOTON) 113
TABLE 31 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 113
TABLE 32 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 113
TABLE 33 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY PRODUCT FORM, 2023–2030 (USD MILLION) 113
TABLE 34 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY PRODUCT FORM, 2023–2030 (KILOTON) 114
TABLE 35 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 114
TABLE 36 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 114
TABLE 37 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (USD MILLION) 115
TABLE 38 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (KILOTON) 115
TABLE 39 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 116
TABLE 40 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 116
TABLE 41 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (USD MILLION) 117
TABLE 42 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (KILOTON) 117
TABLE 43 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 117
TABLE 44 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 118
TABLE 45 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (USD MILLION) 119
TABLE 46 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (KILOTON) 119
TABLE 47 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 119
TABLE 48 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 120
TABLE 49 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 121
TABLE 50 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 121
TABLE 51 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 121
TABLE 52 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 122
TABLE 53 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (USD MILLION) 123
TABLE 54 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (KILOTON) 123
TABLE 55 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 123
TABLE 56 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 124
TABLE 57 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 58 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (KILOTON) 126
TABLE 59 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 126
TABLE 60 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 126
TABLE 61 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (USD MILLION) 127
TABLE 62 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (KILOTON) 127
TABLE 63 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 127
TABLE 64 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 128
TABLE 65 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 129
TABLE 66 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 129
TABLE 67 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 129
TABLE 68 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 130
TABLE 69 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 131
TABLE 70 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 131
TABLE 71 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131
TABLE 72 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 132
TABLE 73 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (USD MILLION) 133
TABLE 74 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (KILOTON) 133
TABLE 75 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 133
TABLE 76 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 134
TABLE 77 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (USD MILLION) 134
TABLE 78 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (KILOTON) 135
TABLE 79 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 135
TABLE 80 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 135
TABLE 81 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (USD MILLION) 136
TABLE 82 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (KILOTON) 137
TABLE 83 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 137
TABLE 84 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 137
TABLE 85 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (USD MILLION) 138
TABLE 86 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (KILOTON) 139
TABLE 87 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 139
TABLE 88 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 139
TABLE 89 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 140
TABLE 90 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 141
TABLE 91 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 141
TABLE 92 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 141
TABLE 93 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 142
TABLE 94 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 142
TABLE 95 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 143
TABLE 96 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 143
TABLE 97 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 144
TABLE 98 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 144
TABLE 99 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 144
TABLE 100 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 145
TABLE 101 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (USD MILLION) 146
TABLE 102 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (KILOTON) 146
TABLE 103 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 147
TABLE 104 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 147
TABLE 105 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 106 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY COUNTRY, 2023–2030 (KILOTON) 148
TABLE 107 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (USD MILLION) 148
TABLE 108 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (KILOTON) 148
TABLE 109 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY PRODUCT FORM, 2023–2030 (USD MILLION) 149
TABLE 110 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY PRODUCT FORM, 2023–2030 (KILOTON) 149
TABLE 111 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 149
TABLE 112 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 150
TABLE 113 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (USD MILLION) 151
TABLE 114 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (KILOTON) 151
TABLE 115 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 151
TABLE 116 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 152
TABLE 117 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 152
TABLE 118 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 153
TABLE 119 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 153
TABLE 120 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 153
TABLE 121 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 154
TABLE 122 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 154
TABLE 123 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 155
TABLE 124 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 155
TABLE 125 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 126 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY COUNTRY, 2023–2030 (KILOTON) 156
TABLE 127 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (USD MILLION) 156
TABLE 128 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE, BY GRADE, 2023–2030 (KILOTON) 156
TABLE 129 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY PRODUCT FORM, 2023–2030 (USD MILLION) 157
TABLE 130 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY PRODUCT FORM, 2023–2030 (KILOTON) 157
TABLE 131 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 157
TABLE 132 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 158
TABLE 133 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 158
TABLE 134 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 159
TABLE 135 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 159
TABLE 136 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 159
TABLE 137 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 160
TABLE 138 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 160
TABLE 139 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 161
TABLE 140 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 161
TABLE 141 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 162
TABLE 142 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 162
TABLE 143 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 162
TABLE 144 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 163
TABLE 145 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 146 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (KILOTON) 164
TABLE 147 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 164
TABLE 148 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 164
TABLE 149 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (USD MILLION) 164
TABLE 150 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (KILOTON) 165
TABLE 151 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 165
TABLE 152 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 165
TABLE 153 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (USD MILLION) 166
TABLE 154 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (KILOTON) 166
TABLE 155 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 166
TABLE 156 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 167
TABLE 157 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 167
TABLE 158 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 168
TABLE 159 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 168
TABLE 160 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 168
TABLE 161 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (USD MILLION) 169
TABLE 162 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE,
2023–2030 (KILOTON) 169
TABLE 163 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 170
TABLE 164 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 170
TABLE 165 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 171
TABLE 166 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 171
TABLE 167 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 171
TABLE 168 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 172
TABLE 169 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (USD MILLION) 172
TABLE 170 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY GRADE, 2023–2030 (KILOTON) 173
TABLE 171 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 173
TABLE 172 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET,
BY APPLICATION, 2023–2030 (KILOTON) 173
TABLE 173 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 174
TABLE 174 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 174
TABLE 175 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 174
TABLE 176 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 175
TABLE 177 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS BETWEEN
JANUARY 2021 AND NOVEMBER 2025 176
TABLE 178 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DEGREE OF COMPETITION 178
TABLE 179 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: REGION FOOTPRINT 187
TABLE 180 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: GRADE FOOTPRINT 187
TABLE 181 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET:
PRODUCT FORM FOOTPRINT 188
TABLE 182 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: APPLICATION FOOTPRINT 188
TABLE 183 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DETAILED
LIST OF KEY STARTUPS/SMES 191
TABLE 184 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 192
TABLE 185 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DEALS,
JANUARY 2021–NOVEMBER 2025 193
TABLE 186 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: EXPANSIONS, JANUARY 2021–NOVEMBER 2025 194
TABLE 187 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2025 194
TABLE 188 K+S AKTIENGESELLSCHAFT: COMPANY OVERVIEW 195
TABLE 189 K+S AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 196
TABLE 190 K+S AKTIENGESELLSCHAFT: OTHERS 197
TABLE 191 SÜDWESTDEUTSCHE SALZWERKE AG: COMPANY OVERVIEW 199
TABLE 192 SÜDWESTDEUTSCHE SALZWERKE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 200
TABLE 193 DOMINION SALT: COMPANY OVERVIEW 203
TABLE 194 DOMINION SALT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 203
TABLE 195 MORTON SALT, INC.: COMPANY OVERVIEW 205
TABLE 196 MORTON SALT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 205
TABLE 197 SALINEN AUSTRIA AG: COMPANY OVERVIEW 207
TABLE 198 SALINEN AUSTRIA AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 207
TABLE 199 MERCK KGAA: COMPANY OVERVIEW 209
TABLE 200 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 211
TABLE 201 MERCK KGAA: EXPANSIONS 211
TABLE 202 GROUPE SALINS: COMPANY OVERVIEW 213
TABLE 203 GROUPE SALINS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 214
TABLE 204 GROUPE SALINS: DEALS 214
TABLE 205 HUB SALT: COMPANY OVERVIEW 216
TABLE 206 HUB SALT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 216
TABLE 207 JIANGSU PROVINCE QINFEN PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW 218
TABLE 208 JIANGSU PROVINCE QINFEN PHARMACEUTICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 218
TABLE 209 US SALT: COMPANY OVERVIEW 220
TABLE 210 US SALT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 220
TABLE 211 NANDU CHEMICALS: COMPANY OVERVIEW 221
TABLE 212 MACCO ORGANIQUES, S.R.O.: COMPANY OVERVIEW 222
TABLE 213 J J CHEMICALS: COMPANY OVERVIEW 223
TABLE 214 SALT MINERALS GMBH: COMPANY OVERVIEW 224
TABLE 215 HITECH MINERALS AND CHEMICALS GROUP: COMPANY OVERVIEW 225
TABLE 216 TIANJIN HENGHAIXIN INTERNATIONAL TRADING CO., LTD.: COMPANY OVERVIEW 226
TABLE 217 MARKHOR SALT CO.: COMPANY OVERVIEW 227
TABLE 218 ABHAY AQUA CHEM: COMPANY OVERVIEW 228
TABLE 219 HAWKINS: COMPANY OVERVIEW 229
TABLE 220 RCI LABSCAN LIMITED: COMPANY OVERVIEW 230
TABLE 221 GLENTHAM LIFE SCIENCES LIMITED: COMPANY OVERVIEW 231
TABLE 222 FENGCHEN GROUP CO., LTD: COMPANY OVERVIEW 232
TABLE 223 DHANRAJ SUGAR PVT. LTD.: COMPANY OVERVIEW 233
TABLE 224 SD FINE-CHEM LTD: COMPANY OVERVIEW 234
TABLE 225 VM CHEMICALS: COMPANY OVERVIEW 235
LIST OF FIGURES
FIGURE 1 PHARMACEUTICAL-GRADE MARKET SEGMENTATION AND REGIONAL SCOPE 26
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 29
FIGURE 3 GLOBAL PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, 2025–2030 30
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET (2021–2025) 30
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET DURING FORECAST PERIOD 31
FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN
PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, 2024 32
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 33
FIGURE 8 HIGH DEMAND FOR DIALYSIS TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 34
FIGURE 9 ASIA PACIFIC ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 35
FIGURE 10 LIQUID SEGMENT DOMINATED PHARMACEUTICAL-GRADE MARKET IN 2024 35
FIGURE 11 DIALYSIS SEGMENT ACCOUNTED FOR LARGEST SHARE OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET IN 2024 36
FIGURE 12 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 36
FIGURE 13 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 14 CHRONIC KIDNEY DISEASE RISING AS LEADING CAUSE OF DEATH WORLDWIDE 39
FIGURE 15 CHRONIC KIDNEY DISEASE PREVALENCE: EUROPE COMPARED TO GLOBAL LEVELS 40
FIGURE 16 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION (2022 VS. 2050) 40
FIGURE 17 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: PORTER’S FIVE FORCES ANALYSIS 49
FIGURE 18 NUMBER OF PEOPLE LIVING IN URBAN AND RURAL AREAS, WORLD (2010–2024) 54
FIGURE 19 GLOBAL TRADE IN MERCHANDISE, 2014–2024 54
FIGURE 20 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: VALUE CHAIN ANALYSIS 56
FIGURE 21 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: ECOSYSTEM ANALYSIS 58
FIGURE 22 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE OFFERED BY KEY PLAYERS, BY GRADE, 2024 (USD/KG) 59
FIGURE 23 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE, BY REGION, 2023–2025 (USD/KG) 60
FIGURE 24 IMPORT SCENARIO FOR HS CODE 250100-COMPLIANT PRODUCTS,
BY COUNTRY, 2020–2024 61
FIGURE 25 EXPORT SCENARIO FOR HS CODE 250100-COMPLIANT PRODUCTS,
BY COUNTRY, 2020–2024 63
FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 65
FIGURE 27 LIST OF MAJOR PATENTS RELATED TO PHARMACEUTICAL-GRADE SODIUM CHLORIDE, 2015–2024 73
FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED FOR PHARMACEUTICAL-GRADE SODIUM CHLORIDE, 2015–2024 74
FIGURE 29 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET DECISION-MAKING FACTORS 89
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION 89
FIGURE 31 KEY BUYING CRITERIA, BY APPLICATION 90
FIGURE 32 ADOPTION BARRIERS & INTERNAL CHALLENGES 92
FIGURE 33 HD-NACL SEGMENT TO DOMINATE MARKET IN 2025 96
FIGURE 34 LIQUID SEGMENT TO DOMINATE MARKET IN 2025 100
FIGURE 35 DIALYSIS SEGMENT TO DOMINATE MARKET IN 2025 103
FIGURE 36 ASIA PACIFIC TO ACCOUNT FOR LARGEST SHARE OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET DURING FORECAST PERIOD 110
FIGURE 37 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET SNAPSHOT 112
FIGURE 38 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET SNAPSHOT 125
FIGURE 39 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024 (USD BILLION) 177
FIGURE 40 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET SHARE ANALYSIS, 2024 178
FIGURE 41 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY VALUATION 181
FIGURE 42 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET:
FINANCIAL MATRIX (EV/EBITDA RATIO) 181
FIGURE 43 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET:
YEAR-TO-DATE PRICE AND FIVE-YEAR STOCK BETA 182
FIGURE 44 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: BRAND/PRODUCT COMPARISON 183
FIGURE 45 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 185
FIGURE 46 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY FOOTPRINT 186
FIGURE 47 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 190
FIGURE 48 K+S AKTIENGESELLSCHAFT: COMPANY SNAPSHOT 196
FIGURE 49 SÜDWESTDEUTSCHE SALZWERKE AG: COMPANY SNAPSHOT 200
FIGURE 50 MERCK KGAA: COMPANY SNAPSHOT 210
FIGURE 51 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: RESEARCH DESIGN 236
FIGURE 52 BREAKDOWN OF INTERVIEWS WITH EXPERTS 239
FIGURE 53 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 239
FIGURE 54 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 240
FIGURE 55 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: APPROACH 1 240
FIGURE 56 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 241
FIGURE 57 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DATA TRIANGULATION 242
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11
- 鉄道試験市場規模、シェア、動向、2032年までの世界予測 2025-12-10